Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Funding
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.
September 18, 2023
U.K. charity to offer $1.6M in grants for research on muscle-wasting diseases
U.K. research projects will benefit from 1.3 million pounds ($1.6 million) in grants to improve diagnostic testing and potential new treatments for muscle-wasting and -weakening conditions.
September 14, 2023
NIH awarding $50.3M to establish multiomics consortium
The U.S. National Institutes of Health (NIH) announced that it will award $50.3 million over five years to establish a multiomics research consortium.
September 14, 2023
Actome outlines sequencing expansion plans as EU funding kicks in
Actome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”
September 7, 2023
Day Zero Diagnostics awarded SBIR grant to develop fecal transplant safety assay
Boston-based Day Zero Diagnostics is receiving research funding to support the development of a pharmacovigilance assay to enhance the safety and efficacy of fecal microbiota transplants (FMT) in clinical trials.
September 1, 2023
Co-Diagnostics awarded over $2M from Bill & Melinda Gates Foundation for TB and HPV tests
Dwight Egan, CEO of Co-Diagnostics, said the grants would help support the worldwide effort to prevent the spread of both TB and HPV in countries where they have been endemic killers for generations.
July 26, 2023
CellChorus awarded two grants to accelerate single-cell analysis platform
The grants will be used to accelerate the development of CellChorus’ Time-lapse Imaging Microscopy in Nanowell Grids (TIMING) platform for single-cell analysis.
June 30, 2023
Consortium nabs $10M European grant to develop drug response tests for CKD
The Prime-CKD consortium is funded by Horizon Europe. Approximately $1 million of the total amount is targeted for commercial translation activities to be undertaken by Renalytix.
January 26, 2023
Hologic awarded $19M by BARDA to develop COVID-19 assays to FDA IVD standards
Hologic announced that the funding will be used to bring its two COVID assays up to the FDA’s IVD standards.
November 2, 2022
Day Zero awarded $8.2 million in CARB-X funding
Day Zero is developing diagnostic tests that use genome sequencing and machine-learning algorithms to rapidly identify pathogens and their antibacterial-resistance profiles.
October 20, 2022
Diadem nabs $2.5M to further validate Alzheimer’s blood test
The two-year grant will enable Diadem, a company that has been developing a blood-based test for the early prediction of Alzheimer's disease (AD), to leverage data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a longitudinal multicenter study designed to enable development of biomarkers for the early detection and tracking of AD.
September 6, 2022
VolitionRx prices $6M public offering
The company said that gross proceeds to Volition from the offering are expected to be $6 million. Volition also granted the underwriter a 30-day option to purchase up to an additional 450,000 shares of its common stock at the public offering price. The offering is expected to close on or about August 2.
July 28, 2022
Page 1 of 4
Next Page
